Carcinosarcoma, true malignant mixed tumor, of the parotid is an extremely rare tumor. Pathologically, it is composed of malignant epithelial and malignant mesenchymal elements. The carcinosarcoma of the salivary glands comprised only 0.04% to 0.16% of all malignant salivary tumors with 65% occurring in the parotid gland. This tumor has an aggressive characteristic and is often regarded as a high-grade tumor with distant metastasis occurring in 54% of the patients. Patients usually present between 60 and 65 years of age and most series report no sex predominance. Radiologically, this tumor has a low attenuation center with a thick-enhancing wall and can be misdiagnosed deep neck infection in the parapharyngeal space. In this report, the authors report a patient of true malignant mixed tumor of the parotid gland mimicking as deep neck infection. Radiologic and histologic features including immunohistochemical results are discussed. (C) 2017 by Mutaz B. Habal, MD.
http://ift.tt/2kN9wWV
http://ift.tt/2koqy01
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Subcutaneous zygomycosis presenting as soft-tissue ‘tumour’ over scapula – case report and review of literature : 2016-10-06T18-09-02Z Sou...
-
Abstract Objectives We examined the effect of biologic disease-modifying anti-rheumatic drugs on the time to pregnancy in patients with ...
-
Publication date: Available online 2 August 2017 Source: Neuroscience Research Author(s): Mamoru Takeda, Masanori Nasu, Takuya Kanazawa, ...
-
Abstract Objectives We present an overview of the literature on caregiver stress in children with craniosynostosis and report common tre...
-
by Barbara Tress, Elisabeth S. Dorn, Jan S. Suchodolski, Tariq Nisar, Prajesh Ravindran, Karin Weber, Katrin Hartmann, Bianka S. Schulz The...
-
Abstract Background In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling,...
-
A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway.Related Articles A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway. Eur J Pharmacol...
-
Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00306932607174,00302841026182, alsfakia@gmail.com http://ift.tt/...
-
Abstract Limited literature is available on the use of fine needle aspiration (FNA) for skin tumors. Awareness of cytological features of ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου